Dental considerations in asplenic patients

Journal of the American Dental Association

Volumn 127, Issue 9, 1996, Pages 1359-1363

  De Rossi, Scott S ^a   Glick, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; DENTAL CARE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; REVIEW; SPLEEN; SPLENECTOMY;

BACTEREMIA; DENTAL CARE FOR CHRONICALLY ILL; HUMANS; IMMUNOCOMPROMISED HOST; SPLEEN; SPLENECTOMY;

EID: 0030236882     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1996.0447     Document Type: Article

References (40)

1. Graves EJ. Detailed diagnosis and procedures, national hospital discharge survey, 1990. Hyattsville, Md.: National Center for Health Statistics. Vital Health Stat 13. 1992 June;113:1-225.
2. Terezhalmy GT, Hall EH. The asplenic patient: a consideration for antimicrobial prophylaxis. Oral Surg Oral Med Oral Pathol 1984;57(1):114-7.
3. Bohnsack JF, Brown EJ. The role of the spleen in resistance to infection. Ann Rev Med 1986;37:49-59.
4. Hosea SW, Brown EJ, Hamburger MI, Frank MM. Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 1981;304:245-50.
5. Malangoni MA, Dawes LG, Droege EA, Rao SA, Collier D, Almagro UA. Splenic phagocytic function after partial splenectomy and splenic autotransplantation. Arch Surg 1985;120:275-8.
6. Scher KS, Wroczynski AF, Jones CW. Protection from postsplenectomy sepsis: effect of prophylactic penicillin and pneumococcal vaccine on clearance of type 3 Pneumococcus. Surgery 1983;93:792-9.
7. Francke EL, Neu HC. Postsplenectomy infection. Surg Clin North Am 1981;61(1):135-55.
8. Kafidi KT, Rotschafer JC. Bacterial vaccines for splenectomized patients. Drug Intell Clin Pharm 1988;22(3):192-7.
9. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med 1990;88(5N):33N-42N.
10. O'Sullivan ST, Reardon CM, O'Donnell JA, Kirwan WO, Brady MP. How safe is splenectomy? Ir J Med Sci 1994;163:374-8.
11. Dietrich PY, Henry-Amar M, Cosset JM, Bodis S, Bosq J, Hayat M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 1994;84:1209-15.
12. Powars D, Overturf G. Penicillin in sickle cell anemia: a panacea for the lost spleen? [editorial] Am J Dis Child 1987;141(3):250-2.
13. Liote F, Angle J, Gilmore N, Osterland CK. Asplenism and systemic lupus erythematosus. Clin Reumatol 1995;14:220-3.
14. Shaw JHF, Print CG. Postsplenectomy sepsis. Br J Surg 1989;76:1074-81.
15. Styrt B. Complications of asplenia and hyposplenism-persistent uncertainties. West J Med 1992;157:461-3.
16. Green JB, Schackford SR, Sise MJ, Fridlund P. Late septic complications in adults following splenectomy for trauma: a prospective analysis in 144 patients. J Trauma 1986;26:999-1004.
17. Chaikof EL, McCabe CJ. Fatal overwhelming postsplenectomy infection. Am J Surg 1985;149:534-9.
18. Ellison EC, Fabri PJ. Complications of splenectomy: etiology, prevention, and management. Surg Clin North Am 1983;63:1313-30.
19. Hazlewood M, Kumararatne DS. The spleen? Who needs it anyway? Clin Exp Immunol 1992;89:327-9.
20. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rates: actual versus perceived risks. Br J Surg 1991;78:1031-8.
21. Malangoni MA, Dillon LD, Klamer TW, Condon RE. Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma. Surgery 1984;96(4):775-81.
22. Pallasch TJ, Slots J. Antibiotic prophylaxis and the medically compromised patient. Periodontol 2000 1996;10:107-38.
23. Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis: a review. Medicine (Baltimore) 1977;56(1):61-77.
24. Nisengard RJ, Newman MG. Oral microbiology and immunology. 2nd ed. Philadelphia: Saunders; 1994:120-8.
25. Read RC, Finch RG. Prophylaxis after splenectomy. J Antimicrob Chemother 1994;33(1):4-6.
26. Cullingford GL, Watkins DN, Watts ADJ, Mallon DF. Severe late postsplenectomy infection. Br J Surg 1991;78:716-21.
27. Duncombe AS, Dudley JM, Slater NGP, Treacher DF. Overwhelming pneumococcal sepsis postsplenectomy. Lancet 1987;1:570.
28. Llibre J, Cucurull J, Aloy A, Hernandez JA. Antimicrobial prophylaxis for dental extractions after splenectomy [letter]. Lancet 1991;337:1485-6.
29. Evans D. Fatal postsplenectomy sepsis despite prophylaxis with penicillin and pneumococcal vaccine [letter]. Lancet 1984;1:1124.
30. Makris M, Greaves M, Winfield DA, Preston FE, Lillyman JS. Long-term management after splenectomy. Lifelong penicillin unproved in trials ... [letter]. BMJ 1994;308(6921):131-2.
31. White KS, Covington D, Churchill P, Maxwell JG, Norman KS, Clancy TV. Patient awareness of health precautions after splenectomy. Am J Infect Control 1991;19(1):36-41.
32. Finch RG, Read R. Long-term management after splenectomy. ... and may be ineffective [letter]. BMJ 1994;308(6921):132.
33. Garcia-Suarez J, Prieto A, Reyes E, et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Haemotol 1995;89:653-5.
34. Luce EB, Montgomery MT, Redding SW. The prevalence of cardiac pathosis in patients with systemic lupus erythematosus. Oral Surg 1990;70:590-2.
35. Glick M. Glucocorticosteroid replacement therapy: literature review and suggested replacement therapy. Oral Surg Oral Med Oral Pathol 1989;67:614-20.
36. Glick M. Dental management of patients with HIV. Carol Stream, Ill.: Quintessence Publishing Co.; 1994:215-54.
37. Levene NA, Varon D, Shtalrid M, Berrebi A. Chronic active hepatitis following splenectomy for autoimmune thrombocytopenia. Isr J Med Sci 1991;27(4):199-201.
38. Huygen K, Abramowicz D, Vandenbussche P, et al. Spleen cell cytokine secretion in mycobacterium bovis BCG-infected mice. Infect Immun 1992;60(7):2880-6.
39. Mellemkjaer L, Olsen JH, Linet MS, Gridley G, McLaughlin JK. Cancer risk after splenectomy. Cancer 1995;75:577-83.
40. Tura S, Fiacchini M, Zinzani PL, Brusamolino E, Gobbi PG, Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993;11:925-30.